Home LiteratureArticle Details
PMID: 7830580 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates.

Molecular microbiology ·Vol. 14 ·No. 2 ·1994-10-00 ·Pages 371-80

Belland RJ, Morrison SG, Ison C, Huang WM

Abstract

Neisseria gonorrhoeae homologues of gyrA and parC have been identified using hybridization probes generated from conserved regions of diverse gyrA genes. These genes have been tentatively identified as gyrA and parC, based on predicted amino acid sequence homologies to known GyrA homologues from numerous bacterial species and to ParC from Escherichia coli and Salmonella typhimurium. The gyrA gene maps to a physical location distant from the gyrB locus on the gonococcal chromosome, which is similar to the situation found in E. coli. The parC gene is not closely linked (i.e. greater than 9 kb) to an identifiable parE gene in N. gonorrhoeae. The gonococcal GyrA is slightly larger than its E. coli homologue and contains several small insertions near the C-terminus of the predicted open reading frame. A series of ciprofloxacin-resistant mutants were selected by passage of N. gonorrhoeae on increasing concentrations of the antibiotic. Sequential passage resulted in the selection of isolates with minimum inhibitory concentrations approximately 10,000-fold higher than the parental strain. Mutations within gyrA resulted in low to moderate levels of resistance, while strains with high-level resistance acquired analogous mutations in both gyrA and parC. Resistance mutations were readily transferred between N. gonorrhoeae strains by transformation. The frequencies of transformation, resulting in different levels of ciprofloxacin resistance, further support the notion that both gyrA and parC genes are involved in the establishment of extreme levels of ciprofloxacin resistance.

Related Genes
MeSH Terms
Amino Acid Sequence Chromosome Mapping Chromosomes, Bacterial Ciprofloxacin/pharmacology DNA Gyrase DNA Topoisomerase IV DNA Topoisomerases, Type I/chemistry,genetics DNA Topoisomerases, Type II/chemistry,genetics Drug Resistance, Microbial Escherichia coli/genetics Genes, Bacterial Molecular Sequence Data Mutation Neisseria gonorrhoeae/chemistry,drug effects,genetics Sequence Alignment Transformation, Bacterial
Chemicals
Ciprofloxacin DNA Topoisomerase IV DNA Topoisomerases, Type I DNA Gyrase DNA Topoisomerases, Type II
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Belland R J
Laboratory of Microbial Structure and Function, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, Montana 59840.
Morrison S G
Ison C
Huang W M
Article Info
Journal
Molecular microbiology
Abbr.
Mol Microbiol
ISSN
0950-382X
Published
1994-10-00
Pages
371-80
Language
English
Region
England
NLM ID
8712028
Subset
IM
Grants
NIGMS NIH HHS · GM21960 · United States
Databases
GENBANK
U08817, U08907
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com